![Luke Walker](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Luke Walker
Directeur/Bestuurslid bij
ZENTALIS PHARMACEUTICALS, INC.
Vermogen: 557 834 $ op 30-09-2026
Profiel
Dr. Luke N.
Walker, MD, is a Chief Medical Officer at Umoja Biopharma, Inc., an Independent Director at Context Therapeutics, Inc. and an Independent Director at Zentalis Pharmaceuticals, Inc. He is on the Board of Directors at Context Therapeutics, Inc. and Zentalis Pharmaceuticals, Inc. Dr. Walker was previously employed as a Chief Medical Officer by Harpoon Therapeutics, Inc., a Vice President-Clinical Development by Seagen, Inc., and a Vice President-Clinical Development by CASCADIAN THERAPEUTICS INC.
He received his doctorate degree from the University of Oklahoma College of Medicine.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 16-06-2026 | 201.384 ( 0,21% ) | 557 834 $ | 30-09-2026 | |
| 24-06-2026 | 0 ( -.--% ) | - $ | 30-09-2026 |
Actieve functies van Luke Walker
| Bedrijven | Functie | Begin |
|---|---|---|
| ZENTALIS PHARMACEUTICALS, INC. | Directeur/Bestuurslid | 29-05-2024 |
| CONTEXT THERAPEUTICS INC. | Directeur/Bestuurslid | 04-09-2024 |
Umoja Biopharma, Inc.
 Umoja Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals for treatment of cancer therapies | Hoofd Techniek/Wetenschap/O&O | 01-01-2025 |
Eerdere bekende functies van Luke Walker
| Bedrijven | Functie | Einde |
|---|---|---|
| HARPOON THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-08-2024 |
| SEAGEN INC. | Corporate Officer/Principal | 01-10-2022 |
| CASCADIAN THERAPEUTICS INC (USA) | Hoofd Techniek/Wetenschap/O&O | 09-03-2018 |
Opleiding van Luke Walker
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
53
Eerstegraads connecties
7
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 7 |
|---|---|
Seagen, Inc.
 Seagen, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes cancer medicines | Health Technology |
Cascadian Therapeutics LLC
 Cascadian Therapeutics LLC Medical SpecialtiesHealth Technology Develops therapeutic products for the treatment of cancer | Health Technology |
University of Oklahoma College of Medicine
 University of Oklahoma College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harpoon Therapeutics, Inc.
 Harpoon Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage immunotherapy company that develops T-cell engagers to treat cancer and other diseases | Health Technology |
Zentalis Pharmaceuticals, Inc.
 Zentalis Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops clinical therapeutics for targeting fundamental cancer pathways | Health Technology |
Umoja Biopharma, Inc.
Umoja Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals for treatment of cancer therapies | Health Technology |
Context Therapeutics, Inc.
 Context Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company which develops treatment options for women living with hormone-dependent cancer | Health Technology |
